The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Endotoxins and Other Sepsis Triggers
Abstract
Endotoxin, or more accurately termed bacterial lipopolysaccharide (LPS), is recognized as the most potent microbial mediator implicated in the pathogenesis of sepsis and septic shock. Yet despite its discovery well over a century ago, the fundamental role of circulating endotoxin in the blood of most patients with septic shock remains enigmatic and a subject of considerable controversy. LPS is the most prominent 'alarm molecule' sensed by the host's early warning system of innate immunity presaging the threat of invasion of the internal milieu by Gram-negative bacterial pathogens. In small doses within a localized tissue space, LPS signaling is advantageous to the host in orchestrating an appropriate antimicrobial defense and bacterial clearance mechanisms. Conversely, the sudden release of large quantities of LPS into the bloodstream is clearly deleterious to the host, initiating the release of a dysregulated and potentially lethal array of inflammatory mediators and procoagulant factors in the systemic circulation. The massive host response to this single bacterial pattern recognition molecule is sufficient to generate diffuse endothelial injury, tissue hypoperfusion, disseminated intravascular coagulation and refractory shock. Numerous attempts to block endotoxin activity in clinical trials with septic patients have met with inconsistent and largely negative results. Yet the groundbreaking discoveries within the past decade into the precise molecular basis for LPS-mediated cellular activation and tissue injury has rekindled optimism that a new generation of therapies that specifically disrupt LPS signaling might succeed. Other microbial mediators found in Gram-positive bacterial and viral and fungal pathogens are now appreciated to activate many of the same host defense networks induced by LPS. This information is providing novel interventions in the continuing effots to improve the care of septic patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
The Pathophysiology and Treatment of Sepsis
Hotchkiss, R. S., & Karl, I. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021333 · Cited by 4,097
Phylogenetic Perspectives in Innate Immunity
Hoffmann, J. A., Kafatos, F. C., Janeway, C. A., & Ezekowitz, R. A. B. (1999) · Science · doi:10.1126/science.284.5418.1313 · Cited by 2,492
The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex
Park, B. S., Song, D. H., Kim, H. M., Choi, B.-S., Lee, H., & Lee, J.-O. (2009) · Nature · doi:10.1038/nature07830 · Cited by 2,428
Akira, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r300028200 · Cited by 1,479
Activation of Endothelial Cell Protease Activated Receptor 1 by the Protein C Pathway
Riewald, M., Petrovan, R. J., Donner, A., Mueller, B. M., & Ruf, W. (2002) · Science · doi:10.1126/science.1071699 · Cited by 831
Role of Toll-Like Receptors in Infection and Immunity: Clinical Implications
Cristofaro, P. A., & Opal, S. M. (2006) · Drugs · doi:10.2165/00003495-200666010-00002 · Cited by 708
Self-citationOpal, S. M., Scannon, P. J., Vincent, J., White, M., Carroll, S. F., Palardy, J. E., Parejo, N. A., Pribble, J. P., & Lemke, J. H. (1999) · The Journal of Infectious Diseases · doi:10.1086/315093 · Cited by 609
Self-citationInsights into host responses against pathogens from transcriptional profiling
Jenner, R. G., & Young, R. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1126 · Cited by 587
Host–pathogen interactions in sepsis
van der Poll, T., & Opal, S. M. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70265-7 · Cited by 553
Self-citationMolecular biology of inflammation and sepsis: A primer*
Cinel, I., & Opal, S. M. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819267fb · Cited by 387
Self-citationCoagulation abnormalities in critically ill patients.
Levi, M. M., & Opal, S. M. (2006) · Critical Care · doi:10.1186/cc4975 · Cited by 315
Self-citationClinical Gram-positive sepsis: Does it fundamentally differ from Gram-negative bacterial sepsis?
Opal, S. M., & Cohen, J. (1999) · Critical Care Medicine · doi:10.1097/00003246-199908000-00039 · Cited by 259
Self-citationOPAL, S. (2007) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2007.03.006 · Cited by 231
Self-citationFrontal and stealth attack strategies in microbial pathogenesis
Merrell, D. S., & Falkow, S. (2004) · Nature · doi:10.1038/nature02760 · Cited by 213
Activation of Toll-Like Receptor 9 by DNA from Different Bacterial Species
Dalpke, A., Frank, J., Peter, M., & Heeg, K. (2006) · Infection and Immunity · doi:10.1128/iai.74.2.940-946.2006 · Cited by 209
Pridmore, A. C., Wyllie, D. H., Abdillahi, F. A., Steeghs, L., van der Ley, P., Dower, S., & Read, R. C. (2001) · The Journal of Infectious Diseases · doi:10.1086/317647 · Cited by 150
Interactions of Toll-like receptors with fungi
Levitz, S. M. (2004) · Microbes and Infection · doi:10.1016/j.micinf.2004.08.014 · Cited by 140
Evolution and integration of innate immune recognition systems: the Toll-like receptors
Takeda, K. (2005) · Journal of Endotoxin Research · doi:10.1177/09680519050110011101 · Cited by 129
Relative concentrations of endotoxin-binding proteins in body fluids during infection
Opal, S. M., Palardy, J., MARRA, M. N., McKelligon, B. M., Scott, R. W., & Fisher, C. J. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91767-1 · Cited by 93
Self-citationSriskandan, S. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl173 · Cited by 90
Differential Gene Expression in Gram-negative and Gram-positive Sepsis
Yu, S., Chen, H., Yang, P., Peck, K., Tsai, M.-H., Chen, J. J. W., & Lin, F. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200211-1278oc · Cited by 80
Procoagulant protein levels are differentially increased during human endotoxemia
Reitsma, P. H., Branger, J., van den Blink, B., Weijer, S., van der Poll, T., & Meijers, J. C. M. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00237.x · Cited by 44
Antibiotic Usage and Resistance
Opal, S. M., & Calandra, T. (2009) · JAMA · doi:10.1001/jama.2009.1774 · Cited by 38
Self-citation
Cited by
The Neutrophil’s Role During Health and Disease
Liew, P. X., & Kubes, P. (2019) · Physiological Reviews · doi:10.1152/physrev.00012.2018 · Cited by 1,175
Bode, C., Zhao, G., Steinhagen, F., Kinjo, T., & Klinman, D. M. (2011) · Expert Review of Vaccines · doi:10.1586/erv.10.174 · Cited by 891
Taverniti, V., & Guglielmetti, S. (2011) · Genes & Nutrition · doi:10.1007/s12263-011-0218-x · Cited by 703
The Intestinal Barrier and Current Techniques for the Assessment of Gut Permeability
Schoultz, I., & Keita, Å. V. (2020) · Cells · doi:10.3390/cells9081909 · Cited by 467
The Role of Gut-Derived Lipopolysaccharides and the Intestinal Barrier in Fatty Liver Diseases
An, L., Wirth, U., Koch, D., Schirren, M., Drefs, M., Koliogiannis, D., Nieß, H., Andrassy, J., Guba, M., Bazhin, A. V., et al. (2022) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-021-05188-7 · Cited by 284
Metadata
- Authors
- Opal, S. M.
- Venue
- Contributions to Nephrology
- Publisher
- S. Karger AG
- Published
- 2010
- Volume
- 167
- Pages
- 14-24
- ISSN
- 0302-5144 (ISSN-L)
- 1662-2782
- OpenAlex
- W1549003425
- Cited by
- 256
- References
- 26
- FWCI
- 42.42
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.